Clinical Trial

A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study is a single-dose, open-label, parallel design phase I clinical study to evaluate the PK characteristics and safety of single subcutaneous injection of ZT002 Injection in participants with different degrees of renal insufficiency and matched participants with normal renal function.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-21
Trial Details
NCT Number NCT07443059
Lead Sponsor Beijing QL Biopharmaceutical Co.,Ltd
Conditions Overweight , Obesity
Enrollment 40 participants
Start Date 2026-04-13
Primary Completion 2026-12-03 (estimated)
Study Completion 2027-03-19 (estimated)
Updated on ClinicalTrials.gov 2026-04-20